![Histological characterization of GLA tissue from the mediastinal mass:... | Download Scientific Diagram Histological characterization of GLA tissue from the mediastinal mass:... | Download Scientific Diagram](https://www.researchgate.net/publication/322918363/figure/fig1/AS:960368838995968@1605981182209/Histological-characterization-of-GLA-tissue-from-the-mediastinal-mass-a-hematoxylin-and.jpg)
Histological characterization of GLA tissue from the mediastinal mass:... | Download Scientific Diagram
![D2-40 immunohistochemical overexpression in cutaneous squamous cell carcinomas: A marker of metastatic risk - ScienceDirect D2-40 immunohistochemical overexpression in cutaneous squamous cell carcinomas: A marker of metastatic risk - ScienceDirect](https://ars.els-cdn.com/content/image/1-s2.0-S0190962212003465-gr2.jpg)
D2-40 immunohistochemical overexpression in cutaneous squamous cell carcinomas: A marker of metastatic risk - ScienceDirect
![D2-40 antibody immunoreactivity in developing human brain, brain tumors and cultured neural cells | Modern Pathology D2-40 antibody immunoreactivity in developing human brain, brain tumors and cultured neural cells | Modern Pathology](https://media.springernature.com/lw685/springer-static/image/art%3A10.1038%2Fmodpathol.3800616/MediaObjects/41379_2006_Article_BF3800616_Fig7_HTML.jpg)
D2-40 antibody immunoreactivity in developing human brain, brain tumors and cultured neural cells | Modern Pathology
![Characterization of patient-derived CLVM EC. a Western blot analysis... | Download Scientific Diagram Characterization of patient-derived CLVM EC. a Western blot analysis... | Download Scientific Diagram](https://www.researchgate.net/publication/341044325/figure/fig2/AS:960369023533064@1605981226371/Characterization-of-patient-derived-CLVM-EC-a-Western-blot-analysis-for-pan-EC-marker.png)
Characterization of patient-derived CLVM EC. a Western blot analysis... | Download Scientific Diagram
![Differential Diagnosis of Cystic Lesions of the Spleen: A Review of Clinical, Imaging and Pathological Findings - Bianca Puello Yocum, Michael Hwang, Hector Mesa, Katrina Collins, 2022 Differential Diagnosis of Cystic Lesions of the Spleen: A Review of Clinical, Imaging and Pathological Findings - Bianca Puello Yocum, Michael Hwang, Hector Mesa, Katrina Collins, 2022](https://journals.sagepub.com/cms/10.1177/10668969221107080/asset/images/large/10.1177_10668969221107080-fig6.jpeg)
Differential Diagnosis of Cystic Lesions of the Spleen: A Review of Clinical, Imaging and Pathological Findings - Bianca Puello Yocum, Michael Hwang, Hector Mesa, Katrina Collins, 2022
![PDF) Lymphatic vessel density and lymph node metastasis in prostate cancer | Lisa Horvath - Academia.edu PDF) Lymphatic vessel density and lymph node metastasis in prostate cancer | Lisa Horvath - Academia.edu](https://0.academia-photos.com/attachment_thumbnails/42506447/mini_magick20190217-2765-1i6v2hw.png?1550442901)
PDF) Lymphatic vessel density and lymph node metastasis in prostate cancer | Lisa Horvath - Academia.edu
![Monoclonal Antibody D2-40, a New Marker of Lymphatic Endothelium, Reacts with Kaposi's Sarcoma and a Subset of Angiosarcomas | Modern Pathology Monoclonal Antibody D2-40, a New Marker of Lymphatic Endothelium, Reacts with Kaposi's Sarcoma and a Subset of Angiosarcomas | Modern Pathology](https://media.springernature.com/full/springer-static/image/art%3A10.1038%2Fmodpathol.3880543/MediaObjects/41379_2002_Article_BF3880543_Fig1_HTML.jpg)
Monoclonal Antibody D2-40, a New Marker of Lymphatic Endothelium, Reacts with Kaposi's Sarcoma and a Subset of Angiosarcomas | Modern Pathology
![Fibro-adipose vascular anomaly (FAVA): three case reports with an emphasis on the mammalian target of rapamycin (mTOR) pathway | Diagnostic Pathology | Full Text Fibro-adipose vascular anomaly (FAVA): three case reports with an emphasis on the mammalian target of rapamycin (mTOR) pathway | Diagnostic Pathology | Full Text](https://media.springernature.com/lw685/springer-static/image/art%3A10.1186%2Fs13000-020-01004-z/MediaObjects/13000_2020_1004_Fig2_HTML.png)
Fibro-adipose vascular anomaly (FAVA): three case reports with an emphasis on the mammalian target of rapamycin (mTOR) pathway | Diagnostic Pathology | Full Text
![Utility of D2-40, a novel mesothelial marker, in the diagnosis of malignant mesothelioma | Modern Pathology Utility of D2-40, a novel mesothelial marker, in the diagnosis of malignant mesothelioma | Modern Pathology](https://media.springernature.com/full/springer-static/image/art%3A10.1038%2Fmodpathol.3800259/MediaObjects/41379_2005_Article_BF3800259_Fig1_HTML.jpg)
Utility of D2-40, a novel mesothelial marker, in the diagnosis of malignant mesothelioma | Modern Pathology
![D2-40 immunohistochemical overexpression in cutaneous squamous cell carcinomas: A marker of metastatic risk - ScienceDirect D2-40 immunohistochemical overexpression in cutaneous squamous cell carcinomas: A marker of metastatic risk - ScienceDirect](https://ars.els-cdn.com/content/image/1-s2.0-S0190962212003465-gr6.jpg)
D2-40 immunohistochemical overexpression in cutaneous squamous cell carcinomas: A marker of metastatic risk - ScienceDirect
![Utility of D2-40, a novel mesothelial marker, in the diagnosis of malignant mesothelioma | Modern Pathology Utility of D2-40, a novel mesothelial marker, in the diagnosis of malignant mesothelioma | Modern Pathology](https://media.springernature.com/lw685/springer-static/image/art%3A10.1038%2Fmodpathol.3800259/MediaObjects/41379_2005_Article_BF3800259_Fig3_HTML.jpg)
Utility of D2-40, a novel mesothelial marker, in the diagnosis of malignant mesothelioma | Modern Pathology
![Monoclonal Antibody D2-40, a New Marker of Lymphatic Endothelium, Reacts with Kaposi's Sarcoma and a Subset of Angiosarcomas | Modern Pathology Monoclonal Antibody D2-40, a New Marker of Lymphatic Endothelium, Reacts with Kaposi's Sarcoma and a Subset of Angiosarcomas | Modern Pathology](https://media.springernature.com/lw685/springer-static/image/art%3A10.1038%2Fmodpathol.3880543/MediaObjects/41379_2002_Article_BF3880543_Fig3_HTML.jpg)
Monoclonal Antibody D2-40, a New Marker of Lymphatic Endothelium, Reacts with Kaposi's Sarcoma and a Subset of Angiosarcomas | Modern Pathology
![D2-40 antibody immunoreactivity in developing human brain, brain tumors and cultured neural cells | Modern Pathology D2-40 antibody immunoreactivity in developing human brain, brain tumors and cultured neural cells | Modern Pathology](https://media.springernature.com/m685/springer-static/image/art%3A10.1038%2Fmodpathol.3800616/MediaObjects/41379_2006_Article_BF3800616_Fig1_HTML.jpg)
D2-40 antibody immunoreactivity in developing human brain, brain tumors and cultured neural cells | Modern Pathology
![Utility of D2-40, a novel mesothelial marker, in the diagnosis of malignant mesothelioma | Modern Pathology Utility of D2-40, a novel mesothelial marker, in the diagnosis of malignant mesothelioma | Modern Pathology](https://media.springernature.com/lw685/springer-static/image/art%3A10.1038%2Fmodpathol.3800259/MediaObjects/41379_2005_Article_BF3800259_Fig4_HTML.jpg)
Utility of D2-40, a novel mesothelial marker, in the diagnosis of malignant mesothelioma | Modern Pathology
![Monoclonal Antibody D2-40, a New Marker of Lymphatic Endothelium, Reacts with Kaposi's Sarcoma and a Subset of Angiosarcomas - ScienceDirect Monoclonal Antibody D2-40, a New Marker of Lymphatic Endothelium, Reacts with Kaposi's Sarcoma and a Subset of Angiosarcomas - ScienceDirect](https://ars.els-cdn.com/content/image/1-s2.0-S0893395222X6300X-cov150h.gif)
Monoclonal Antibody D2-40, a New Marker of Lymphatic Endothelium, Reacts with Kaposi's Sarcoma and a Subset of Angiosarcomas - ScienceDirect
![D2-40 antibody immunoreactivity in developing human brain, brain tumors and cultured neural cells | Modern Pathology D2-40 antibody immunoreactivity in developing human brain, brain tumors and cultured neural cells | Modern Pathology](https://media.springernature.com/lw685/springer-static/image/art%3A10.1038%2Fmodpathol.3800616/MediaObjects/41379_2006_Article_BF3800616_Fig4_HTML.jpg)
D2-40 antibody immunoreactivity in developing human brain, brain tumors and cultured neural cells | Modern Pathology
![Microvessels in Epithelial Ovarian Tumors: High Microvessel Density Is a Significant Feature of Malignant Ovarian Tumors | Anticancer Research Microvessels in Epithelial Ovarian Tumors: High Microvessel Density Is a Significant Feature of Malignant Ovarian Tumors | Anticancer Research](https://ar.iiarjournals.org/content/anticanres/40/12/6923/F1.large.jpg)
Microvessels in Epithelial Ovarian Tumors: High Microvessel Density Is a Significant Feature of Malignant Ovarian Tumors | Anticancer Research
![Lymph vascular invasion in invasive mammary carcinomas identified by the endothelial lymphatic marker D2-40 is associated with other indicators of poor prognosis | BMC Cancer | Full Text Lymph vascular invasion in invasive mammary carcinomas identified by the endothelial lymphatic marker D2-40 is associated with other indicators of poor prognosis | BMC Cancer | Full Text](https://media.springernature.com/lw685/springer-static/image/art%3A10.1186%2F1471-2407-8-64/MediaObjects/12885_2007_Article_1002_Fig2_HTML.jpg)
Lymph vascular invasion in invasive mammary carcinomas identified by the endothelial lymphatic marker D2-40 is associated with other indicators of poor prognosis | BMC Cancer | Full Text
![Low D2-40 immunoreactivity correlates with lymphatic invasion and nodal metastasis in early-stage squamous cell carcinoma of the uterine cervix | Modern Pathology Low D2-40 immunoreactivity correlates with lymphatic invasion and nodal metastasis in early-stage squamous cell carcinoma of the uterine cervix | Modern Pathology](https://media.springernature.com/full/springer-static/image/art%3A10.1038%2Fmodpathol.3800269/MediaObjects/41379_2005_Article_BF3800269_Fig1_HTML.jpg)
Low D2-40 immunoreactivity correlates with lymphatic invasion and nodal metastasis in early-stage squamous cell carcinoma of the uterine cervix | Modern Pathology
![Utility of D2-40, a novel mesothelial marker, in the diagnosis of malignant mesothelioma | Modern Pathology Utility of D2-40, a novel mesothelial marker, in the diagnosis of malignant mesothelioma | Modern Pathology](https://media.springernature.com/lw685/springer-static/image/art%3A10.1038%2Fmodpathol.3800259/MediaObjects/41379_2005_Article_BF3800259_Fig2_HTML.jpg)